New incident report
Incident Report Number: 2008-4112
Registrant Reference Number: Prosar 1-16646133
Registrant Name (Full Legal Name no abbreviations): Syngenta Crop Protection Canada, Inc.
Address: 140 Research Lane, Research Park
City: Guelph
Prov / State: Ontario
Country: Canada
Postal Code: N1G4Z3
Human
Country: CANADA
Prov / State: MANITOBA
PMRA Registration No. 26396 PMRA Submission No. EPA Registration No.
Product Name: Reglone Liquid Herbicide/Desiccant
Yes
Unknown
Site: Unknown / Inconnu
Unknown
Other
Sex: Male
Age: >19 <=64 yrs / >19 <=64 ans
System
Unknown / Inconnu
Yes
Unknown
Unknown
Application
Unknown
Eye
<=15 min / <=15 min
>8 hrs <=24 hrs / > 8 h < = 24 h
1-16646133: A reporter called on 09/17/2008 to report the exposure of her husband to an herbicide and dessicant containing the active ingredient Diquat Dibromide. According to the reporter, her husband was using the product on 09/16/2008 when he accidentally got some of it in his eye. He immediately rinsed his eye with water from a water bottle and the garden hose. He showered 2.5 hours later and flushed his eyes out again. He also used unspecified eye drops at some point on 09/16/2008. On 09/17/2008, her husband developed nasal discharge and ocular discharge, redness, and swelling. The reporter requested the Material Safety Data Sheet (MSDS) for the product. The reporter was advised that ocular exposure to the product may result in significant irritation and prolonged (weeks) impairment of vision. The degree of injury depends upon the amount of material that gets into the eye and how quickly and thoroughly the eye is irrigated. Symptoms after ocular exposure include pain, tearing, swelling, redness, and blurred vision. A recommendation was made to consult an ophthalmologist as antibiotics and/or anti-inflammatories may be indicated. Another reporter (attending physician) called on 09/17/2008 to inquire about treatment recommendations for the patient. The physician was advised of the potential for ocular exposure to result in significant ocular irritation and impairment of vision. Symptoms and factors determining the degree of injury were also reviewed with the physician. A recommendation was made to treat the affected eye with ophthalmic antibiotics to prevent secondary infection and use a steroid ophthalmic preparation if needed as an anti-inflammatory. The physician was also advised that while corneal abrasions are not expected as a result of product exposure, the patient's corneas should be evaluated. On follow up on 09/18/2008, the initial reporter stated that her husband's eye had become more swollen and irritated despite treatment. The reporter was advised that her husband should follow his physician's instructions and consider re-evaluation if no improvement is noted. On follow up on 09/22/2008, the initial reporter stated that her husband's eye is still red, "bumpy" on the inner surface of the eyelid and "drains" consistently. He also complains of a burning sensation when he uses the ophthalmic solution. The reporter stated that her husband is waiting for a referral to an ophthalmologist and requested that the toxicologist at Health and Safety provide a referral for her husband. The reporter was advised that the toxicologist is unable to provide a referral. A recommendation was made for her husband to follow up with his primary physician to obtain a referral to an ophthalmologist since the signs are persistent. No further information was obtained.
Moderate